Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can simple birth kits save lives in flood zones?

NCT ID NCT05640063

Prevention Sponsor: Aga Khan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether providing enhanced delivery and newborn kits, along with training for community health workers, can reduce perinatal deaths compared to standard kits in flood-affected districts of Sindh, Pakistan. Pregnant women in the intervention areas receive the enhanced kits for use at home or at health facilities, aiming to reduce delays in care. The study will measure perinatal mortality rates and specific causes of newborn and maternal deaths.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced delivery and newborn kits provided to pregnant women, along with training for community health workers and healthcare providers.
What this could lead to
If effective, this approach could reduce perinatal and maternal deaths in disaster-affected regions, offering a low-cost, scalable intervention for improving birth outcomes in similar settings.
What could go wrong
The trial is set in specific flood-affected districts, so results may not generalize to other contexts. Implementation challenges in crisis settings could also affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,400 people

The number who actually took part.

Started

Mar 2023

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women in the project sites living in the area till expected date of their delivery. Exclusion Criteria: * The individuals who would not consent to participate in the study voluntarily.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perinatal death are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Perinatal Death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Perinatal death

Contacts and locations

Locations

  • Aga Khan University

    Karachi, Sindh, 74800, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.